Stock 3737 ZHONGZHI PHARMACEUTICAL HOLDINGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Zhongzhi Pharmaceutical Holdings Limited

Equities

3737

KYG989611085

Pharmaceuticals

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:22 2024-04-29 am EDT 		5-day change 1st Jan Change
1.18 HKD -3.28% Intraday chart for Zhongzhi Pharmaceutical Holdings Limited -3.28% -16.90%
Mar. 25 Zhongzhi Pharmaceutical's Attributable Jumps in 2023 MT
Mar. 22 Zhongzhi Pharmaceutical Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 13 June 2024 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 1,084 968.4 1,181 696.6 831.4 1,115
Enterprise Value (EV) 1 743.9 707.7 1,058 614.5 606.5 1,097
P/E ratio 12.6 x 8.38 x 8.41 x 13.4 x 7.66 x 6.79 x
Yield 3.16% 4.69% 2.22% - 5.51% 6.33%
Capitalization / Revenue 0.95 x 0.72 x 0.74 x 0.4 x 0.46 x 0.54 x
EV / Revenue 0.65 x 0.53 x 0.66 x 0.35 x 0.33 x 0.54 x
EV / EBITDA 7.26 x 4.25 x 5.07 x 5.02 x 3.94 x 5.11 x
EV / FCF -50.7 x 11.2 x -27.9 x -12.5 x 2.74 x -10.5 x
FCF Yield -1.97% 8.93% -3.58% -8.03% 36.5% -9.48%
Price to Book 1.53 x 1.27 x 1.44 x 0.78 x 0.83 x 1.06 x
Nbr of stocks (in thousands) 840,000 840,000 840,000 863,600 863,600 863,600
Reference price 2 1.291 1.153 1.406 0.8067 0.9627 1.291
Announcement Date 4/9/19 4/14/20 4/14/21 4/19/22 4/20/23 4/19/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 1,142 1,342 1,604 1,746 1,826 2,050
EBITDA 1 102.4 166.5 208.6 122.3 153.9 214.8
EBIT 1 78.2 136.8 148.2 79.58 103.5 163.9
Operating Margin 6.85% 10.19% 9.24% 4.56% 5.67% 8%
Earnings before Tax (EBT) 1 101.8 155.9 167.2 61.81 130.7 207.6
Net income 1 85.07 114.7 138.5 52.13 106.4 162.8
Net margin 7.45% 8.55% 8.64% 2.98% 5.83% 7.94%
EPS 2 0.1021 0.1376 0.1671 0.0600 0.1256 0.1900
Free Cash Flow 1 -14.66 63.18 -37.9 -49.32 221.5 -104.1
FCF margin -1.28% 4.71% -2.36% -2.82% 12.13% -5.08%
FCF Conversion (EBITDA) - 37.95% - - 143.95% -
FCF Conversion (Net income) - 55.09% - - 208.2% -
Dividend per Share 2 0.0408 0.0541 0.0312 - 0.0531 0.0817
Announcement Date 4/9/19 4/14/20 4/14/21 4/19/22 4/20/23 4/19/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 340 261 123 82.1 225 17.4
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -14.7 63.2 -37.9 -49.3 221 -104
ROE (net income / shareholders' equity) 12.4% 15.6% 17.5% 6.08% 11.2% 15.9%
ROA (Net income/ Total Assets) 5.08% 7.46% 6.86% 3.38% 3.81% 5.59%
Assets 1 1,674 1,538 2,020 1,543 2,795 2,914
Book Value Per Share 2 0.8400 0.9100 0.9800 1.040 1.160 1.210
Cash Flow per Share 2 0.4000 0.4500 0.3500 0.2700 0.4400 0.1900
Capex 1 75.2 57.2 114 186 88.4 169
Capex / Sales 6.58% 4.26% 7.11% 10.64% 4.84% 8.25%
Announcement Date 4/9/19 4/14/20 4/14/21 4/19/22 4/20/23 4/19/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

1st Jan change Capi.
ZHONGZHI PHARMACEUTICAL HOLDINGS LIMITED Stock Zhongzhi Pharmaceutical Holdings Limited
-16.90% 135M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+20.81% 43.34B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+20.44% 21.96B
SANDOZ GROUP AG Stock Sandoz Group AG
+11.97% 14.09B
CIPLA LIMITED Stock Cipla Limited
+12.97% 13.64B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+39.74% 11.43B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-8.59% 6.86B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+8.46% 5.22B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 3737 Stock
  4. Financials Zhongzhi Pharmaceutical Holdings Limited